SEC Form 4 · accession 0001645627-18-000079
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President
Period of report
Dec 11, 2018
Accepted (ET)
Dec 14, 2018 · 5:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 11, 2018 | P | 2,000 | $0.022 | A | 26,343,898 | D | |
| Common Stock | Dec 11, 2018 | P | 2,000 | $0.0228 | A | 26,345,898 | D | |
| Common Stock | Dec 11, 2018 | P | 2,000 | $0.0235 | A | 26,347,898 | D | |
| Common Stock | Dec 12, 2018 | P | 2,000 | $0.0214 | A | 26,349,898 | D | |
| Common Stock | Dec 12, 2018 | P | 2,000 | $0.0212 | A | 26,351,898 | D | |
| Common Stock | Dec 12, 2018 | P | 2,000 | $0.0212 | A | 26,353,898 | D | |
| Common Stock | Dec 12, 2018 | P | 1,000 | $0.0213 | A | 26,354,898 | D | |
| Common Stock | Dec 12, 2018 | P | 2,000 | $0.0218 | A | 26,356,898 | D | |
| Common Stock | Dec 12, 2018 | P | 1,000 | $0.0218 | A | 26,357,898 | D | |
| Common Stock | Dec 13, 2018 | P | 1,000 | $0.0245 | A | 26,358,898 | D |
Table II — derivative securities
No Table II lines on this filing.